Rigel Pharmaceuticals (RIGL) Change in Inventory (2018 - 2026)
Rigel Pharmaceuticals' quarterly Change in Inventory came in at $581000.0 in Q1 2026, up 141.12% year-on-year from $240960.7 in Q1 2025, and up 151.37% quarter-over-quarter from -$1.1 million in Q4 2025.
Rigel Pharmaceuticals has reported Change in Inventory for 9 years, with the latest figure at $581000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Inventory rose 141.12% year-over-year to $581000.0; the trailing twelve-month figure through Mar 2026 stood at $7.6 million (up 270.02% YoY), and the FY2025 full-year result was $5.6 million, up 837.57% from the prior year.
- Change in Inventory for Q1 2026 stood at $581000.0, up from -$1.1 million in the prior quarter.
- The five-year high for Change in Inventory was $8.4 million in Q2 2025, with the low at -$3.3 million in Q3 2024.
- Average Change in Inventory over 5 years is $391588.2, with a median of -$188000.0 recorded in 2025.
- Year-over-year, Change in Inventory surged 1640.18% in 2023 and plunged 1090.04% in 2024.
- Tracing RIGL's Change in Inventory over 5 years: stood at $2.0 million in 2022, then tumbled by 227.63% to -$2.5 million in 2023, then gained by 23.94% to -$1.9 million in 2024, then soared by 41.25% to -$1.1 million in 2025, then jumped by 151.37% to $581000.0 in 2026.
- The last three Change in Inventory figures came in at $581000.0 (Q1 2026), -$1.1 million (Q4 2025), and -$188000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 665.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 97.70 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -26.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.32 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | 581,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 581,000.00 |
| Mar 31, 2026 | 581,000.00 |
| Dec 31, 2025 | -1.13 Mn |
| Dec 31, 2025 | -1.13 Mn |
| Sep 30, 2025 | -188,000.00 |
| Sep 30, 2025 | -188,000.00 |
| Jun 30, 2025 | 8.37 Mn |
| Jun 30, 2025 | 8.37 Mn |
| Mar 31, 2025 | -1.41 Mn |
| Mar 31, 2025 | -1.41 Mn |
| Dec 31, 2024 | -1.93 Mn |
| Dec 31, 2024 | -1.93 Mn |
| Sep 30, 2024 | -3.34 Mn |
| Sep 30, 2024 | -3.34 Mn |
| Jun 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 2.20 Mn |
| Mar 31, 2024 | 2.31 Mn |
| Mar 31, 2024 | 2.31 Mn |
| Dec 31, 2023 | -2.53 Mn |
| Dec 31, 2023 | -2.53 Mn |
| Sep 30, 2023 | -281,000.00 |
| Sep 30, 2023 | -281,000.00 |
| Jun 30, 2023 | -309,000.00 |
| Jun 30, 2023 | -309,000.00 |
| Mar 31, 2023 | 1.95 Mn |
| Mar 31, 2023 | 1.95 Mn |
| Dec 31, 2022 | 1.98 Mn |
| Dec 31, 2022 | 1.98 Mn |
| Sep 30, 2022 | 877,000.00 |
| Sep 30, 2022 | 877,000.00 |
| Jun 30, 2022 | -595,000.00 |
| Jun 30, 2022 | -595,000.00 |
| Mar 31, 2022 | 112,000.00 |
| Mar 31, 2022 | 112,000.00 |
| Dec 31, 2021 | -450,000.00 |
| Dec 31, 2021 | -450,000.00 |
| Sep 30, 2021 | 167,000.00 |
| Sep 30, 2021 | 167,000.00 |
| Jun 30, 2021 | -114,000.00 |
| Jun 30, 2021 | -114,000.00 |
| Mar 31, 2021 | 5.27 Mn |
| Mar 31, 2021 | 5.27 Mn |
| Dec 31, 2020 | -109,000.00 |
| Dec 31, 2020 | -109,000.00 |
| Sep 30, 2020 | -42,000.00 |
| Sep 30, 2020 | -42,000.00 |
| Jun 30, 2020 | 35,000.00 |
| Jun 30, 2020 | 35,000.00 |
| Mar 31, 2020 | 242,000.00 |
| Mar 31, 2020 | 242,000.00 |
| Dec 31, 2019 | 171,000.00 |
| Dec 31, 2019 | 171,000.00 |
| Sep 30, 2019 | -50,000.00 |
| Sep 30, 2019 | -50,000.00 |
| Jun 30, 2019 | 42,000.00 |
| Jun 30, 2019 | 42,000.00 |
| Mar 31, 2019 | 203,000.00 |
| Mar 31, 2019 | 203,000.00 |
| Dec 31, 2018 | 341,000.00 |
| Dec 31, 2018 | 341,000.00 |
| Sep 30, 2018 | 22,000.00 |
| Sep 30, 2018 | 22,000.00 |